S.2554

Requires SHBP, SEHBP, Medicaid, and NJ FamilyCare to cover anti-obesity medications.

Introduced·2/8/24
Introduced Text

New Jersey S2554 requires SHBP, SEHBP, Medicaid, and NJ FamilyCare to cover anti-obesity medications.

New Jersey S2554 mandates that the State Health Benefits Program (SHBP), the School Employees' Health Benefits Program (SEHBP), the Medicaid program, and the NJ FamilyCare program cover anti-obesity medications. This coverage applies to individuals diagnosed with obesity or an obesity-related medical condition, prescribed the medication by a certified health care provider, and dispensed by an approved pharmacy. The bill aims to address the high prevalence of obesity in New Jersey, which affects 28.6% of residents, and to reduce obesity-related health problems and associated costs.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Health, Human Services and Senior Citizens Committee
Next
Session adjourned — paused until it reconvenes

Sponsors

D
1
0
Democratic CaucusRepublican Caucus

History

Feb 8, 2024

Senate

Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee